IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $260,000 | -32.5% | 7,899 | -43.7% | 0.18% | -34.4% |
| Q2 2020 | $385,000 | -67.3% | 14,032 | -64.3% | 0.28% | -73.2% |
| Q1 2020 | $1,177,000 | +75.1% | 39,322 | +61.9% | 1.04% | +75.3% |
| Q4 2019 | $672,000 | +74.1% | 24,294 | +14.5% | 0.59% | +56.3% |
| Q3 2019 | $386,000 | -31.3% | 21,213 | -7.4% | 0.38% | -25.6% |
| Q2 2019 | $562,000 | +13.8% | 22,903 | -55.9% | 0.51% | -1.5% |
| Q1 2019 | $494,000 | -3.3% | 51,959 | -10.0% | 0.52% | -3.9% |
| Q4 2018 | $511,000 | – | 57,724 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |